a biotechnology company developing a new category of high-performance
neuromodulators for use in treating aesthetic and therapeutic conditions, announced the appointment of Chris Nolet to the companys Board of Directors.
Revance is a clinical-stage biotechnology company focused on the development, manufacturing, and commercialization of novel
neuromodulators for multiple aesthetic and therapeutic indications.
New studies are needed to get more information about the role of
neuromodulators in the etiology and treatment of dysfunctional voiding.
H Huang, and Department of Psychology, Nanjing University of Chinese Medicine, Nanjing, 210023 China, "Differentiation of primary emotions through
neuromodulators: review of literature," International Journal of Neurology Research, vol.
In recent decades, hydrogen sulfide (H[sub]2S) has been identified as a novel endogenous vasodilator and
neuromodulator due to its antioxidation capacity.
Zinc: Zinc homeostasis in the brain is closely associated with neuronal activity, and considered an endogenous
neuromodulator in synaptic neurotransmission.
According to the researchers, this behavior of the nucleus accumbens neurons could be caused by a
neuromodulator called adenosine.
Hypocretins/orexins is a
neuromodulator discovered in the late 90s.
The molecular mechanisms involved in this
neuromodulator effect of H2S are not clear, although the effects, both exogenous and endogenous, of H2S in primarily cultured medullary neurons elevate [[Ca2+].sub.i] levels, mainly by increasing the calcium influx and mobilizing intracellular [Ca.sup.2+] stores from ER from primarily cultured rat medullary neurons.
"
Neuromodulator" brain chemicals, which pace neuron activity, can directly wake the brain or lull it to sleep by changing ion concentrations.
This is a randomized, controlled, blind, crossover trial comparing cycling versus continuous programming of a sacral
neuromodulator in women diagnosed with overactive bladder (OAB).
(NYSE MKT: MDGN) has acquired neuroFix Therapeutics, LLC, the developer of NFC-1, a first-in-class, non-stimulant metabotropic glutamate receptor (mGluR)
neuromodulator, the company said.
